Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

IBIO Stock May Have a Longer ‘Trial Period’

By Josh Enomoto, InvestorPlace Contributor

One of the few beneficiaries of the coronavirus are pharmaceutical firms that may offer a solution. But with IBIO stock and similar names, the upside pathway may not be as limited as previously thought.

CCL Stock Is Staring at a Very Bleak Future

By Josh Enomoto, InvestorPlace Contributor

Due to coronavirus fears causing major disruptions to the cruise liner industry, CCL stock naturally suffered huge losses. But the volatility may not be over due to severe sector and branding damages.

Chesapeake Energy Stock Is Past Due for Its Execution Date

By Josh Enomoto, InvestorPlace Contributor

Prior to the coronavirus, CHK stock was an extremely risky play. With it devolving into a pandemic, Chesapeake is simply doomed.

President Trump Will Nuke Alibaba Stock If It Comes to That

By Josh Enomoto, InvestorPlace Contributor

In September 2019, President Trump toyed with the idea of delisting Alibaba stock and other Chinese publicly traded companies. Now in the year of the coronavirus, this idea has far more significance.

9 Recession-Proof Stocks to Disinfect the Coronavirus

By Josh Enomoto, InvestorPlace Contributor

As the coronavirus pandemic worsens, stable but boring recession-proof stocks to buy are suddenly in vogue. Here are the nine picks that might ride this black swan even to profitability.

3M Stock: It’s Not Just About the Masks or the Coronavirus

By Josh Enomoto, InvestorPlace Contributor

With 3M's N95 face masks flying off the shelves, the temporary bull case for MMM stock has some legs. But the raging coronavirus also underlines a potential, deep-seated shift in how we view 3M and similar organizations.

VZ Stock Will Eventually Be a Solid Buy

By Josh Enomoto, InvestorPlace Contributor

Few analysts will question the long-term viability of VZ stock. However, chasing this discount now may not be the best play, considering that worsening events suggest a better deal is coming.

LOW Stock Has Yet to Hit Its Lows

By Josh Enomoto, InvestorPlace Contributor

With panic-buying on the rise, LOW stock seemingly has some upside in the coronavirus. But it’s not turning out that way, giving investors a clear signal to wait for the volatility to subside.

Immediate Risks Weigh on Qualcomm Stock

By Josh Enomoto, InvestorPlace Contributor

Over the long run, it’s easy to have confidence in Qualcomm stock. But coronavirus from China has other plans and from a tactical view, we must respect it.

For Clorox Stock, the Coronavirus Is an Intriguing Catalyst

By Josh Enomoto, InvestorPlace Contributor

The present thesis for Clorox stock is an obvious one: people panic-buying disinfectants helps lifts CLX’s profile. Analysts regard this dynamic as a fleeting one but what if it’s not?

Load More